Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Misfolded alpha-synuclein (AS) and other neurodegenerative disorder proteins display prion-like transmission of protein aggregation. Factors responsible for the initiation of AS aggregation are unknown. To evaluate the role of amyloid proteins made by the microbiota we exposed aged rats and transgenic C . elegans to E . coli producing the extracellular bacterial amyloid protein curli. Rats exposed to curli-producing bacteria displayed increased neuronal AS deposition in both gut and brain and enhanced microgliosis and astrogliosis compared to rats exposed to either mutant bacteria unable to synthesize curli, or to vehicle alone. Animals exposed to curli producing bacteria also had more expression of TLR2, IL-6 and TNF in the brain than the other two groups. There were no differences among the rat groups in survival, body weight, inflammation in the mouth, retina, kidneys or gut epithelia, and circulating cytokine levels. AS-expressing C . elegans fed on curli-producing bacteria also had enhanced AS aggregation. These results suggest that bacterial amyloid functions as a trigger to initiate AS aggregation through cross-seeding and also primes responses of the innate immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A study of Fischer-344 wild-type rats, which spontaneously develop asymptomatic α-synuclein pathology in the enteric nervous system in old age, showed that they will begin to develop pathological α-synuclein deposits in the brain and parkinsonian motor symptoms when their microbiome is disturbed through introduction of Escherichia coli [86, 87].”
From The gut–brain axis in early Parkinson’s disease: from prodrome to prevention (2025) · cites this paper as [86]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Exposure to curli-producing bacteria increases the deposition and accumulation of a-synuclein in intestinal ganglion cells (myenteric plexus and submucosa) and the brain, respectively, as well as increasing the inflammatory response in the brain.131”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“Our findings of microgliosis, astrogliosis and enhanced expression of IL-6, TLR2 and TNF in the brain following curli exposure suggest the occurrence of an enhanced local sterile inflammatory response to AS in the brain.”
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 1×
“The precise role of protein aggregation and inflammation in neurodegeneration remains unclear 33 .”
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Regression Models for Ordinal Data
McCullagh, P. (1980) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1980.tb01109.x · Cited by 4,453
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Self-citationα-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130
Peripheral education of the immune system by colonic commensal microbiota
Lathrop, S. K., Bloom, S. M., Rao, S. M., Nutsch, K., Lio, C.-W., Santacruz, N., Peterson, D. A., Stappenbeck, T. S., & Hsieh, C.-S. (2011) · Nature · doi:10.1038/nature10434 · Cited by 1,034 · cited 2×
“The following antibodies were used: α -synuclein (Syn-1; BD Bioscience, San Diego, CA); TNF α , glial fibrillary acidic protein (GFAP) (GA5), TH, and NeuN (Millipore, County Cork, Ireland); β -actin (Sigma-Aldrich, St Louis, MO); NF-κ B p65 and phospho-NF-κ B p65 (Cell Signaling, Beverly, MA); IL-1 β and IL6 (Abcam, C…”
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901
Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin
Zenaro, E., Pietronigro, E., Bianca, V. D., Piacentino, G., Marongiu, L., Budui, S., Turano, E., Rossi, B., Angiari, S., Dusi, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3913 · Cited by 865 · cited 1×
“It has recently been reported that circulating neutrophils contribute to AS pathology in transgenic mice 15 .”
Cited by
Items 101–200 of 463
New hope for Parkinson’s disease treatment: Targeting gut microbiota
Fan, H., Sheng, S., & Zhang, F. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13916 · Cited by 66
Nagu, P., Parashar, A., Behl, T., & Mehta, V. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01829-3 · Cited by 70
“The elevated level of various inflammatory modulators such as TLR2, TNF, and Il-6 was also observed in the brain of these animals (Chen et al. 2016).”
BackgroundHuynh, V. A., Takala, T. M., Murros, K. E., Diwedi, B., & Saris, P. E. J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1181315 · Cited by 73
Modulation of Glial Function in Health, Aging, and Neurodegenerative Disease
Hanslik, K. L., Marino, K. M., & Ulland, T. K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.718324 · Cited by 72
Neuroinflammation in neurodegeneration via microbial infections
Tran, V. T. A., Lee, L. P., & Cho, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907804 · Cited by 81
Tomlinson, J. J., Shutinoski, B., Dong, L., Meng, F., Elleithy, D., Lengacher, N. A., Nguyen, A. P., Cron, G. O., Jiang, Q., Roberson, E. D., et al. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1726-7 · Cited by 63
“Of note, changes in a-synuclein metabolism, including the up-regulation of the gene and its post-translational modification (phosphorylation; oligomerization), have been shown to occur downstream of microbial insults in vivo (Beatman et al. 2015; Jang et al. 2009; Chen et al. 2016).”
BackgroundContribution of Gut Microbiota to Immunological Changes in Alzheimer’s Disease
van Olst, L., Roks, S. J. M., Kamermans, A., Verhaar, B. J. H., van der Geest, A. M., Muller, M., van der Flier, W. M., & de Vries, H. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683068 · Cited by 74
Wanapaisan, P., Chuansangeam, M., Nopnipa, S., Mathuranyanon, R., Nonthabenjawan, N., Ngamsombat, C., Thientunyakit, T., & Muangpaisan, W. (2022) · Neurodegenerative Diseases · doi:10.1159/000526947 · Cited by 72
Somatostatin in Alzheimer's disease: A new Role for an Old Player
Solarski, M., Wang, H., Wille, H., & Schmitt-Ulms, G. (2018) · Prion · doi:10.1080/19336896.2017.1405207 · Cited by 62
“suggested before [11,12], to date this scenario has not been adequately considered in the context of AD.”
BackgroundGut-to-Brain α-Synuclein Transmission in Parkinson’s Disease: Evidence for Prion-like Mechanisms
Chen, M., & Mor, D. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087205 · Cited by 74
“In the same study, aged rats that were fed curli-producing bacteria showed an increase in α-synuclein deposition in the ENS, as well as in the hippocampus and striatum [90].”
BackgroundThe interplay between microbiota and brain-gut axis in epilepsy treatment
Zhu, H., Wang, W., & Li, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1276551 · Cited by 74
Nutrition, gut microbiota, and alzheimer’s disease
Romanenko, M., Kholin, V., Koliada, A., & Vaiserman, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.712673 · Cited by 56
“In addition, bacterial amyloid proteins prime the immune system, thus triggering an immune response to the brain amyloids and promoting the alpha-synuclein aggregation (63, 64).”
BackgroundMitochondrial dysfunction in Alzheimer’s disease: a key frontier for future targeted therapies
Wang, S., Liao, Z., Zhang, Q., Han, X., Liu, C., & Wang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1484373 · Cited by 84
Labrie, V., & Brundin, P. (2017) · Journal of Innate Immunity · doi:10.1159/000479653 · Cited by 57
Friedland, R. P., McMillan, J. D., & Kurlawala, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051652 · Cited by 56
“that feeding bacterial amyloid to aged rats accelerates AS deposition in the gut, as well as in the brain [13].”
BackgroundSelf-citationWalker, A. C., Bhargava, R., Vaziriyan-Sani, A. S., Pourciau, C., Donahue, E. T., Dove, A. S., Gebhardt, M. J., Ellward, G. L., Romeo, T., & Czyż, D. M. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009510 · Cited by 62
“elegans Parkinson’s disease models [74].”
Gentile, F., Doneddu, P. E., Riva, N., Nobile‐Orazio, E., & Quattrini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207471 · Cited by 59
“coli producing amyloid protein Curli cross‐seeds with α‐synuclein and stimulates protein aggregation in both the gut and the brain in WT mice [164].”
BackgroundGI infections are associated with an increased risk of Parkinson’s disease
Nerius, M., Doblhammer, G., & Tamgüney, G. (2020) · Gut · doi:10.1136/gutjnl-2019-318822 · Cited by 56
Miller, A. L., Pasternak, J. A., Medeiros, N. J., Nicastro, L. K., Tursi, S. A., Hansen, E. G., Krochak, R., Sokaribo, A. S., MacKenzie, K. D., Palmer, M. B., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008591 · Cited by 62
Targeting gut microbiota to alleviate neuroinflammation in Alzheimer’s disease
Nguyen, V. T. T., & Endres, K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114418 · Cited by 60
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
Jurcău, A., Andronie-Cioară, F. L., Nistor-Cseppento, C. D., Pașcalău, N., Rus, M., Vasca, E., & Jurcău, M. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914582 · Cited by 63
“…proof of viral and bacterial infections being able to upregulate enteric α -synuclein [233] as well as by showing that repeated administration of an extracellular amyloid protein secreted by Escherichia coli (curli) to rats enhances neuronal deposition of α -synuclein in the gut and brain [234].”
Clinical and Preclinical Studies of Fermented Foods and Their Effects on Alzheimer’s Disease
Kumar, M. R., Azizi, N. F., Yeap, S. K., Abdullah, J. O., Khalid, M., Omar, A. R., Osman, M. A., Leow, T. C., Mortadza, S. A. S., & Alitheen, N. B. (2022) · Antioxidants · doi:10.3390/antiox11050883 · Cited by 65
Prion-like Domains in Eukaryotic Viruses
Tetz, G. V., & Tetz, V. (2018) · Scientific Reports · doi:10.1038/s41598-018-27256-w · Cited by 54
Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson’s Disease
van Kessel, S. P., & El Aidy, S. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191780 · Cited by 52
Ruiz‐González, C., Román, P., Rueda‐Ruzafa, L., Rodríguez-Arrastia, M. J., & Cardona, D. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110189 · Cited by 55
Bacterial Extracellular DNA Promotes β-Amyloid Aggregation
Tetz, G. V., & Tetz, V. (2021) · Microorganisms · doi:10.3390/microorganisms9061301 · Cited by 52
“This raises the unanswered question of why some people who have bacteria or PAMPs present in their CNS develop neurodegeneration and some do not, since the presence of even a small amount of bacterial PAMPs activates microglia and astrocytes, and considering bacterial eDNA as a strain-specific triggering factor of Aβ…”
BackgroundEmerging Roles of Functional Bacterial Amyloids in Gene Regulation, Toxicity, and Immunomodulation
Salinas, N., Povolotsky, T. L., Landau, M., & Kolodkin‐Gal, I. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00062-20 · Cited by 59
“ogy is only witnessed in genetically predisposed mice (149).”
BackgroundZhong, S.-R., Kuang, Q., Zhang, F., Chen, B., & Zhong, Z.-G. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0206 · Cited by 59
“demonstrated that oral administration of curli can accelerate α-syn aggregation and increase its deposition in the gut and the brain, priming the innate immune system and neuroinflammation in the CNS [107].”
BackgroundGastrointestinal disorders in Parkinson’s disease and other Lewy body diseases
Hirayama, M., Nishiwaki, H., Hamaguchi, T., & Ohno, K. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00511-2 · Cited by 66
“Oral administration of the bacterial amyloid protein, curli, increases the levels of in fl ammatory markers and the aggregation of α -synuclein in the rat brain 26 .”
Exploring pathological link between antimicrobial and amyloid peptides
Tang, Y., Zhang, Y., Zhang, D., Liu, Y., Nussinov, R., & Zheng, J. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00878a · Cited by 55
Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders
Chandra, S., Alam, M. T., Dey, J., Sasidharan, B. C. P., Ray, U., Srivastava, A. K., Gandhi, S., & Tripathi, P. P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200413091101 · Cited by 52
Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine
Javed, I., Cui, X., Wang, X., Mortimer, M., Andrikopoulos, N. K., Li, Y., Davis, T. P., Zhao, Y., Ke, P. C., & Chen, C. (2020) · ACS Nano · doi:10.1021/acsnano.0c07258 · Cited by 48
Rani, L., & Mondal, A. C. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.01.001 · Cited by 50
Guo, Y., Wang, L., Lu, J., Jiao, J., Yang, Y., Zhao, H., Zhang, L., & Zheng, H. Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11931 · Cited by 53
“coli able to produce curly amyloid fibrils, the deposition of Aβ in the gut and brain neurons increased and the proliferation of glial cells and astrocytes was enhanced (18).”
BackgroundSánchez-Tapia, M., Mimenza-Alvarado, A., Granados-Domínguez, L., Flores-López, A., López-Barradas, A., Ortiz, V., Pérez-Cruz, C., Sánchez-Vidal, H., Hernández-Acosta, J., Ávila-Funes, J. A., et al. (2023) · Nutrients · doi:10.3390/nu15040932 · Cited by 47
“Thus, we have to consider that gut microbiota could play an important role in the development of neurological diseases, since bacteria can produce functional extracellular amyloid proteins [27].”
BackgroundMicrobial sensing in the intestine
Wan, T., Wang, Y., He, K., & Zhu, S. (2023) · Protein & Cell · doi:10.1093/procel/pwad028 · Cited by 51
Impact of Microbiome–Brain Communication on Neuroinflammation and Neurodegeneration
Stolzer, I., Scherer, E., Süß, P., Rothhammer, V., Winner, B., Neurath, M. F., & Günther, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914925 · Cited by 49
Microglia and gut microbiota: A double-edged sword in Alzheimer's disease
Bano, N., Khan, S., Ahamad, S., Kanshana, J. S., Dar, N. J., Khan, S. J., Nazir, A., & Bhat, S. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102515 · Cited by 52
González-Sanmiguel, J., Schuh, C. M. A. P., Muñoz-Montesino, C., Contreras‐Kallens, P., Aguayo, L. G., & Aguayo, S. D. (2020) · Cells · doi:10.3390/cells9112476 · Cited by 50
α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic Challenges
Arias-Carrión, Ó., Guerra‐Crespo, M., Padilla-Godínez, F. J., Soto-Rojas, L. O., & Manjarrez, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115405 · Cited by 58
“Moreover, gut microbiota alterations may serve as biomarkers and disease modifiers, as microbiome imbalances can induce aSyn aggregation in animal models, highlighting a possible causal link [254] and the potential for implementing microbiome-based therapies [255].”
What Is the Evidence that Parkinson’s Disease Is a Prion Disorder, Which Originates in the Gut?
Kujawska, M., & Jodynis‐Liebert, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113573 · Cited by 51
“coli producing bacterial amyloid protein curli, which is a β-sheet-rich protein capable of cross-seeding, an increased neuronal expression of α-synuclein has been demonstrated both in the submucosal and myenteric plexus as well as in the brain, which correlated well with enhanced microgliosis and astrogliosis [100].”
BackgroundHashim, H. M., & Makpol, S. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1007166 · Cited by 49
Prion-Like Domains in Phagobiota
Tetz, G. V., & Tetz, V. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02239 · Cited by 42
“Moreover, prion determinants were shown to participate in the inter-kingdom communication between prokaryotes and eukaryotes, leading to the alterations in the amyloidogenesis in Caenorhabditis elegans following its colonization with amyloid-producing bacteria (Chen et al., 2016).”
BackgroundEnvironmental triggers of Parkinson's disease – Implications of the Braak and dual-hit hypotheses
Chen, H., Wang, K., Scheperjans, F., & Killinger, B. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105601 · Cited by 48
The Presence of Alpha‐Synuclein in Skin from Melanoma and Patients with Parkinson's Disease
Rodríguez‐Leyva, I., Chi-Ahumada, É., Mejía, M., Castanedo-Cázares, J. P., Eng, W., Saikaly, S. K., Carrizales-Rodríguez, J., Levine, T., Norman, R. A., & Jiménez-Capdeville, M. E. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12494 · Cited by 43
Christensen, L. F. B., Jensen, K. F., Nielsen, J., Vad, B. S., Christiansen, G., & Otzen, D. E. (2019) · ACS Omega · doi:10.1021/acsomega.8b03590 · Cited by 43
Nutraceuticals: An integrative approach to starve Parkinson’s disease
Lama, A., Pirozzi, C., Avagliano, C., Annunziata, C., Mollica, M. P., Calignano, A., Meli, R., & Raso, G. M. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100037 · Cited by 45
“…as a key component of the mitochondrial electron transport chain, actively involved in ATP production, counteracting 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity, and blocking the electron transfer between complex 1 as well as other complexes (Cleren et al., 2008).”
BackgroundBhoite, S. S., Han, Y., Ruotolo, B. T., & Chapman, M. R. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102088 · Cited by 43
“Exposure to Escherichia coli curli fibers increases α-synuclein aggregation in the guts and brains of rats and Caenorhabditis elegans (39).”
BackgroundColonic inflammation affects myenteric alpha-synuclein in nonhuman primates
Resnikoff, H., Metzger, J. M., Lopez, M., Bondarenko, V., Mejia, A., Simmons, H. A., & Emborg, M. E. (2019) · Journal of Inflammation Research · doi:10.2147/jir.s196552 · Cited by 42
Microbiome-based therapies for Parkinson’s disease
Alam, M., Abbas, K., Mustafa, M., Usmani, N., & Habib, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1496616 · Cited by 50
Shiadeh, S. M. J., Chan, W. K., Rasmusson, S., Hassan, N., Joca, S. R. L., Westberg, L., Elfvin, A., Mallard, C. E., & Ardalan, M. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03504-2 · Cited by 58
“Treating rats with Curli-producing bacteria on a regular basis results in increased production of cytokines, microglia, and astrocytes [181].”
The impact of indigenous microbes on Parkinson's disease
Sampson, T. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.014 · Cited by 41
“coli, has been experimentally demonstrated to increase inflammatory markers and ⍺Syn aggregation in the brains of rats following oral exposure (Chen et al., 2016).”
BackgroundMicrobiota in cerebrovascular disease: A key player and future therapeutic target
Tonomura, S., Ihara, M., & Friedland, R. P. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20918031 · Cited by 43
“coli and other bacteria, can accelerate cross-seeding of amyloid formation in vivo and in vitro.(90) Of particular interest are the findings of Venegas et al.”
BackgroundSelf-citationDhami, M., Raj, K., & Singh, S. (2023) · Aging and Health Research · doi:10.1016/j.ahr.2023.100128 · Cited by 52
Kulcsarova, K., Bang, C., Berg, D., & Schaeffer, E. (2023) · Journal of Parkinson’s Disease · doi:10.3233/jpd-230206 · Cited by 40
Gut microbiota and its metabolites in Alzheimer’s disease: from pathogenesis to treatment
Zou, X., Zou, G., Zou, X., Wang, K., & Chen, Z. (2024) · PeerJ · doi:10.7717/peerj.17061 · Cited by 53
“…studies suggested that the aggregation of misfolded proteins, such as amyloid-beta and tau, and increased bacterial amyloid, such as curli fibers, cause neurodegenerative changes, significantly contributing to AD development ( Chen et al., 2016 ; Pisa et al., 2015 ; Pluta et al., 2020 ).”
BackgroundA viral expression factor behaves as a prion
Nan, H., Chen, H., Tuite, M. F., & Xu, X. (2019) · Nature Communications · doi:10.1038/s41467-018-08180-z · Cited by 40
Ticinesi, A., Mancabelli, L., Carnevali, L., Nouvenne, A., Meschi, T., Rio, D. D., Ventura, M., Sgoifo, A., & Angelino, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215493 · Cited by 44
“…increasedneuronalalpha-synucleindepositionin both the gut and the brain, enhanced microgliosis and astrogliosis, and increased central levels of proin-flammatory cytokines compared to rats exposed to bacteria without the ability to produce amyloids [51].”
Hewel, C., Kaiser, J., Wierczeiko, A., Linke, J., Reinhardt, C., Endres, K., & Gerber, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00113 · Cited by 39
“This leads to the speculation that biofilm components from the gut microbiota are able to cross-seed to the brain, where they induce amyloidogenesis (Lundmark et al., 2005; Chen et al., 2016; Del Tredici and Braak, 2016).”
BackgroundWerner, T., Horváth, I., & Wittung-Stafshede, P. E. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202085 · Cited by 42
Chiu, L. S., & Anderton, R. S. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15892 · Cited by 37
Ma, L., Jiang, X., Huang, Q.-Y., Chen, W., Zhang, H., Pei, H., Cao, Y., Wang, H., & Li, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115244 · Cited by 44
Gut-brain axis: gut dysbiosis and psychiatric disorders in Alzheimer’s and Parkinson’s disease
Denman, C. R., Park, S. M., & Jo, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1268419 · Cited by 47
Synthetic biology engineering of biofilms as nanomaterials factories
Nguyen, P. Q. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160348 · Cited by 39
T cells, α-synuclein and Parkinson disease
Garretti, F., Monahan, C., Sette, A., Agalliu, D., & Sulzer, D. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00023-0 · Cited by 41
Lung endothelium, tau, and amyloids in health and disease
Balczon, R., Lin, M. T., Voth, S. B., Nelson, A. R., Schupp, J. C., Wagener, B. M., Pittet, J., & Stevens, T. (2023) · Physiological Reviews · doi:10.1152/physrev.00006.2023 · Cited by 40
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD
Liang, D., Liu, H., Jin, R., Feng, R., Wang, J., Qin, C., Zhang, R., Chen, Y., Zhang, J., Teng, J., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2276296 · Cited by 40
“33 The results showed that there were no pathological α-syn detected in the intestinal tract of Lrrk2 RP/+ mut curli E . coli at 24 wpfg (Supplementary Figure S4e).”
BackgroundKhan, M. S., Nasiripour, S., & Bopassa, J. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136416 · Cited by 57
The neuromicrobiology of Parkinson’s disease: A unifying theory
Muñoz, M., Empadinhas, N., & Cardoso, S. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101396 · Cited by 39
“The effect of these bacterial amyloid proteins goes beyond in vitro studies since oral administration of curli-synthetizing bacteria in aged rats and nematodes were also confirmed to concomitantly increase the production and aggregation of Asyn (Chen et al., 2016).”
Deidda, G., & Biazzo, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.753915 · Cited by 40
Gut Microbiota and Immune System Dynamics in Parkinson’s and Alzheimer’s Diseases
Kuštrimović, N. Z., Balkhi, S., Bilato, G., & Mortara, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212164 · Cited by 45
Modeling Host-Microbiome Interactions in Caenorhabditis elegans
Gerbaba, T. K., Green-Harrison, L. E., & Buret, A. G. (2017) · Journal of Nematology · doi:10.21307/jofnem-2017-082 · Cited by 40
“To study microbemediated neurodegeneration, human alpha-synuclein (AS) expressed in wild-type worms was used to analyze effects of E. coli amyloid protein curli on AS aggregation (Chen et al., 2016).”
MethodDysbiosis in Parkinson’s disease might be triggered by certain antibiotics
Ternák, G., Kuti, D., & Kovács, K. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109564 · Cited by 40
“These bacterial amyloids have the ability to initiate additional αSyn deposits via cross-seeding [22] and transmit their pathogenic confirmation as prions [23].”
BackgroundRole of the Microbiome in the Pathogenesis of COVID-19
De, R., & Dutta, S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.736397 · Cited by 38
The gut–brain axis in early Parkinson’s disease: from prodrome to prevention
Oliver, P. J., Civitelli, L., & Hu, M. T. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13138-5 · Cited by 42
“…develop asymptomatic α-synuclein pathology in the enteric nervous system in old age, showed that they will begin to develop pathological α-synuclein deposits in the brain and parkinsonian motor symptoms when their microbiome is disturbed through introduction of Escherichia coli [86, 87].”
The Appendix in Parkinson’s Disease: From Vestigial Remnant to Vital Organ?
Killinger, B. A., & Labrie, V. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191703 · Cited by 53
Tan, L. Y., Yeo, X. Y., Bae, H., Lee, D. P. S., Ho, R., Kim, J. E., Jo, D., & Jung, S. (2021) · Life · doi:10.3390/life11070698 · Cited by 36
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Boertien, J. M., Murtomäki, K., Pereira, P. A. B., van der Zee, S., Mertsalmi, T. H., Levo, R., Nojonen, T., Mäkinen, E., Jaakkola, E., Laine, P., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00395-8 · Cited by 38
Evidence for immune system alterations in peripheral biological fluids in Parkinson’s disease
Bartl, M., Xylaki, M., Bähr, M., Weber, S., Trenkwalder, C., & Mollenhauer, B. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105744 · Cited by 33
Park, D. G., Kang, W., Shin, I.-J., Chalita, M., Oh, H.-S., Hyun, D.-W., Kim, H., Chun, J., An, Y.-S., Lee, E. J., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106655 · Cited by 34
“These proteins play a role in bacterial adhesion, biofilm formation, and potentially in the initiation of alpha-synuclein misfolding due to their amyloid properties (Chen et al., 2016).”
BackgroundThe menace within: bacterial amyloids as a trigger for autoimmune and neurodegenerative diseases
Elkins, M., Jain, N., & Tükel, Ç. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102473 · Cited by 35
IUPHAR review: Microbiota-gut-brain axis and its role in neuropsychiatric disorders
Lee, S.-H., Han, C., & Shin, C. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107749 · Cited by 42
Gut Microbiota and Disorders of the Central Nervous System
Vuotto, C., Battistini, L., Caltagirone, C., & Borsellino, G. (2020) · The Neuroscientist · doi:10.1177/1073858420918826 · Cited by 37
Grathwohl, S. A., Quansah, E., Maroof, N., Steiner, J. A., Spycher, L., Benmansour, F., Durán-Pacheco, G., Siebourg‐Polster, J., Oroszlan‐Szovik, K., Remy, H., et al. (2021) · Free Neuropathology · doi:10.17879/freeneuropathology-2021-3326 · Cited by 26
Nargeh, H., Aliabadi, F., Ajami, M., & Pazoki–Toroudi, H. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00923 · Cited by 33
Brain-gut-microbiota axis in Parkinson’s disease: A historical review and future perspective
Dong, S., Sun, M., He, C. H., & Cheng, H. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.02.015 · Cited by 34
Samat, H. N. A., Razali, N. N., Mahadzir, H., Muhammad, T. S. T., Ling, K., Mansor, N. I., & Abidin, S. Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188905 · Cited by 39
“Microbial amyloids can exacerbate inflammatory processes by activating immune receptors like TLR2, producing pro-inflammatory cytokines [124].”
Epigenetic inactivation of the autophagy–lysosomal system in appendix in Parkinson’s disease
Gordevičius, J., Li, P., Marshall, L. L., Killinger, B. A., Lang, S., Ensink, E., Kuhn, N. C., Cui, W., Maroof, N., Lauria, R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25474-x · Cited by 38
Microbes and Parkinson’s disease: from associations to mechanisms
Cannon, T., & Gruenheid, S. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.01.004 · Cited by 35
Gut Bacteria Regulate the Pathogenesis of Huntington’s Disease in Drosophila Model
Chongtham, A., Yoo, J. H., Chin, T. M., Akingbesote, N. D., Huda, A., Marsh, J., & Khoshnan, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.902205 · Cited by 35
“E. coli expressing the functional amyloids curli in the gut has been implicated in α-synuclein aggregation and accelerated PD pathology in the brain of rodents (Chen et al., 2016, Sampson et al., 2020).”
BackgroundSchmit, K. J., Garcia, P., Sciortino, A., Aho, V. T. E., Rodriguez, B. P., Thomas, M. H., Gérardy, J., Acha, I. B., Halder, R., Cialini, C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113071 · Cited by 36
“Our treatment protocol primed the naive untreated microbiome with a ‘‘Westernized’’ fiber-deprived diet,(16) followed by exposure to curli-producing bacteria.(27) We analyzed the mice at gut microbial, behavioral, gastrointestinal, and neuropathological levels.”
BackgroundMethodvan Vuuren, M. J., Nell, T. A., Carr, J. A., Kell, D. B., & Pretorius, E. (2020) · Biomolecules · doi:10.3390/biom11010030 · Cited by 40
Ganz, T., Fainstein, N., Elad, A., Lachish, M., Goldfarb, S., Einstein, O., & Ben‐Hur, T. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02369-8 · Cited by 31
“AD related changes in the enteric nervous system may affect the gut microbiome (53), and reciprocally altered gut microbiome may facilitate AD pathogenesis in the brain through its related neuro-hormones, PAMPs and microbial-derived amyloidogenic proteins (51,52,54).”
BackgroundMicrobiome-based therapeutics for Parkinson's disease
Hamilton, A. M., Krout, I. N., White, A. C., & Sampson, T. R. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00462 · Cited by 33
Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson’s Disease
Dănău, A., Dumitrescu, L., Lefter, A., Tulbă, D., & Popescu, B. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111663 · Cited by 31
The Intestine as a Lifespan- and Proteostasis-Promoting Signaling Tissue
Hodge, F., Bajuszova, V., & van Oosten‐Hawle, P. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.897741 · Cited by 31
“Rats exposed to curli-producing bacteria in their gut, showed increased neuronal alpha-synuclein deposition in both gut and brain, potentially directly via crossseeding of amyloid species and priming certain responses of innate immune cells in the brain, such as glial cells (Chen et al., 2016).”
BackgroundSchymanski, E., Baker, N., Williams, A. J., Singh, R. R., Trezzi, J., Wilmes, P., Kolber, P. L., Krüger, R., Paczia, N., Linster, C. L., et al. (2019) · Environmental Science Processes & Impacts · doi:10.1039/c9em00068b · Cited by 28
The enteric nervous system: “A little brain in the gut”
Annaházi, A., & Schemann, M. (2020) · e-Neuroforum · doi:10.1515/nf-2019-0027 · Cited by 35
“Aged rats exposed to amyloid producing E. coli developed alpha-synuclein deposits both in their gut and brain, accompanied by microgliosis and astrogliosis (Chen et al., 2016).”
BackgroundBiological Functions of Prokaryotic Amyloids in Interspecies Interactions: Facts and Assumptions
Kosolapova, A. O., Antonets, K. S., Belousov, M. V., & Nizhnikov, A. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197240 · Cited by 32
“demonstrated that exposing aged rats to curli-producing bacteria leads to the increase of α-synuclein deposition in neurons in both brain and gut, which is a feature of neurodegenerative disorders [171].”
Parkinson's Disease and the Gut: Models of an Emerging Relationship
Bindas, A. J., Kulkarni, S., Koppes, R. A., & Koppes, A. N. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.071 · Cited by 28
Metadata
- Authors
- Chen, S. G., Stribinskis, V., Rane, M. J., Demuth, D. R., Gozal, E., Roberts, A. M., Jagadapillai, R., Liu, R., Choe, K., Shivakumar, B., Son, F., Jin, S., Kerber, R., Adame, A., Masliah, E., & Friedland, R. P.
- Affiliations
- Case Western Reserve University (US)
- University of Louisville (US)
- University of California San Diego (US)
- Corresponding author
- Friedland, Robert P.
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-10-06
- Volume
- 6
- Issue
- 1
- Pages
- 34477-34477
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5052651
- OpenAlex
- W2528438579
- Semantic Scholar
- 8941d2a0855c5ed0f4d041db3a0b4426e019b757
- Cited by
- 463
- References
- 53
- Citations by year
- 2026: 27 · 2025: 44 · 2024: 62 · 2023: 57 · 2022: 72 · 2021: 74 · 2020: 45 · 2019: 45 · 2018: 17 · 2017: 19 · 2016: 1
- FWCI
- 20.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- University of Louisville
- National Institute on Aging (P50AG005131)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- alpha-synuclein aggregation, curli, bacterial amyloids, prion-like transmission, cross-seeding, gut microbiota, neuroinflammation, microglial activation, astrocyte activation, innate immune response, TLR2, interleukin-6, TNF-α, aged rats, Caenorhabditis elegans, Escherichia coli, neurodegenerative diseases
- MeSH terms
- Amyloid, Animals, Bacterial Proteins, Escherichia coli, Rats, Inbred F344, Caenorhabditis elegans, Escherichia coli Proteins, Rats, alpha-Synuclein, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.